Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'exposure drug'
exposure drug published presentations and documents on DocSlides.
DRUG REACTIONS Adverse drug reactions (ADRs) are a common cause of dermatologic consultation.
by heavin
The . risk for development of a drug eruption is r...
Pre- and Post-Exposure Prophylaxis for HIV
by stefany-barnette
Kevin L. Ard, MD, MPH. October 20, 2016. Learning...
Preventing Occupational Exposure to Hazardous Drugs
by liane-varnes
Consultation Education and Training Division. Mic...
Preventing Occupational Exposure to Hazardous Drugs
by mitsue-stanley
Consultation Education and Training Division. Mic...
Table 1-3. Epidemiologic risk behaviors, risk exposures, and groups at risk
by josephine
for hepatitis A, hepatitis B, and hepatitis C. Hep...
Neonatal Abstinence Syndrome Impact and Treatment of Newborns
by giovanna-bartolotta
Neonatal Abstinence Syndrome Impact and Treatment...
The Early Days of an Investigator in WIHS: Grants and Projects
by mitsue-stanley
By. Bani Tamraz, . Pharm.D. ., Ph.D.. Associate C...
Clinical Pharmacology 2:
by myesha-ticknor
Clinical Pharmacology Considerations During Phase...
Nursing And USP<800>: What’s different from NIOSH and WA Law?
by pamella-moone
Seth Eisenberg RN OCN. ®. BTMCN. ®. Comparison...
Nursing And USP<800>: What’s different from NIOSH and WA Law?
by celsa-spraggs
Seth Eisenberg RN OCN. ®. BTMCN. ®. Comparison...
Neonatal Drug Withdrawal
by trish-goza
Neonatal Drug Withdrawal. This is a nationwide pr...
Periconceptional Antiretroviral Exposure and Central Nervous System and Neural Tube Defects – D
by norah
Antiretroviral Pregnancy Registry. LM Mofenson, V ...
Preventing Occupational Exposure to Hazardous Drugs
by mitsue-stanley
Consultation Education and Training Division. Mic...
HIV Pre-Exposure Prophylaxis (
by cheryl-pisano
PrEP. ). Yuma Health District 5/23/16. Alyssa Gui...
Preventing Occupational Exposure to Hazardous Drugs
by liane-varnes
Consultation Education and Training Division. Mic...
Making Impactful Public Health Policy Change:
by liane-varnes
The Legislative Process from the Inside of the Ma...
Donna E. Sweet, MD, AAHIVS, MACP
by pasty-toler
Professor of Medicine. The University of Kansas S...
Guideline Summary Updated
by stefany-barnette
U.S. . Public Health Service Guidelines for the M...
Toxicology Chapter 9 Toxicology
by taylor
Toxicology. : . study of poisons and . drugs and ...
Figure 4 Figure 4. Cases of illness averted in the general population after Coxiella burne
by priscilla
Moodie CE, Thompson HA, Meltzer MI, Swerdlow DL. P...
An HIV Post-Exposure Prophylaxis Pilot Program Implemented in Public Health Settings in Los Angeles
by brooks507
Implemented in Public Health Settings in Los Angel...
Drug Safety in Pregnancy:
by brianna
Challenges and Solutions. Sonia Hernández-Díaz, ...
BA/BE
by natalia-silvester
in paediatric population: what may be extrapolate...
ASHP Technical Assistance Bulletin on Handling
by karlyn-bohler
Cytotoxic. and Hazardous Drugs. Drug Distributio...
Modeling and Simulation
by lindy-dunigan
in Drug Development. Joint Conference of Europea...
PEP: 2015
by debby-jeon
Francois Venter. Wits Reproductive Health and HIV...
European Medicines Agency 7 Westferry Circus Canary Wharf London E14 4
by ethlyn
ICH Topic E 1 Population Exposure The Extent of Po...
Special Topic: Considerations for Families in the Child Welfare System Affected by Methamphetamine
by white
Child Welfare Training Toolkit. A program of the S...
PEP: INTEREST 2015 Francois Venter
by pasty-toler
Wits Reproductive Health and HIV Institute (RHI)....
Pharmacokinetic and pharmacodynamic considerations for pediatric antifungal dosing
by InLoveWithLife
How the cauliflower had its revenge. OR. Three are...
ARVs & DDIs in pregnancy
by obrien
Scientific Workshop. Improving patient care throug...
The Role of Pre-Exposure Prophylaxis (
by tatyana-admore
PrEP. ) for the Prevention of HIV. Sarah . Kemink...
ImmunoPathogenesis of HIV Disease
by tawny-fly
Overview of HIV Epidemic. Basic biology of HIV-1....
Eric Silberhorn, Ph.D. Environmental Safety Team
by liane-varnes
Division of Scientific Support. Office of New Ani...
Laura L. Hungerford, DVM, MPH, PhD
by karlyn-bohler
Senior Advisor, Science and Policy, ONADE. Profes...
Eric Silberhorn, Ph.D. Environmental Safety Team
by jane-oiler
Division of Scientific Support. Office of New Ani...
Treatment is Effective Behavioral Health is Essential to Health
by yoshiko-marsland
Prevention Works. People Recover. Improving the q...
Global network analysis of drug tolerance, mode of action a
by debby-jeon
methicillin. -resistant . S. . aureus. Bobby Arno...
W orking
by min-jolicoeur
with . Different Groups. Module 3 (f). People who...
Laura L. Hungerford, DVM, MPH, PhD
by tatiana-dople
Senior Advisor, Science and Policy, ONADE. Profes...
Load More...
